Review article · 2025 · Open access
Machine Learning and Artificial Intelligence in Nanomedicine
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, 17(4), e70027 · Published 1 July 2025 · DOI 10.1002/wnan.70027
In brief
“Machine Learning and Artificial Intelligence in Nanomedicine” is a 2025 review article by Wei‐Chun Chou and 3 co-authors, published in Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. OpenAlex counts 205 citations as of 19 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology.
- Citations
- 205
- Most cited in
- 2026 (183)
- Field-weighted impact
- 8.63
- References
- 112
- Authors
- 4
Abstract
Nanomedicine harnesses nanoscale materials, such as lipid, polymeric, and inorganic nanoparticles, to deliver diagnostic or therapeutic agents for cancer, infectious disease, and neurological disorders, among others. However, translating promising nanoparticle designs into clinically approved products remains a challenge. Factors such as particle size, surface chemistry, and payload interactions must be optimized, and preclinical results often fail to predict human efficacy. In recent years, artificial intelligence (AI) and machine learning (ML) have emerged as transformative tools to address these hurdles at every stage of nanomedicine development. By rapidly screening extensive libraries and extracting structure-function relationships, AI-driven models can rationalize nanoparticle formulation, predict biodistribution, and guide optimal design. Techniques like high-throughput DNA barcoding and automated liquid handling facilitate robust, large-scale data collection, feeding into computational pipelines that expedite discovery while reducing reliance on resource-intensive trial-and-error experiments. AI-based platforms also enable improved modeling of protein corona formation, which profoundly affects nanoparticle immunogenicity and cellular uptake. Despite these advances, challenges persist in data standardization, model generalizability, and establishing a clear regulatory framework since no dedicated U.S. Food and Drug Administration (FDA) guidance addresses the intersection of AI and nanomedicine. Overcoming these limitations requires harmonized data sharing, rigorous in vivo validation, and clear ethical and regulatory guidelines. This review summarizes the rapidly evolving landscape of AI in nanomedicine, highlighting key successes in design and preclinical prediction, as well as persistent obstacles to full-scale clinical integration. By illuminating these dynamics, we aim to chart a more efficient path forward in developing next-generation nanomedicine.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Chou, W., Canchola, A., Zhang, F., & Lin, Z. (2025). Machine Learning and Artificial Intelligence in Nanomedicine. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, 17(4), e70027. https://doi.org/10.1002/wnan.70027
MLA 9
Chou, Wei‐Chun, et al. “Machine Learning and Artificial Intelligence in Nanomedicine.” Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, vol. 17, no. 4, 2025, p. e70027. https://doi.org/10.1002/wnan.70027.
Chicago
Chou, Wei‐Chun, Alexa Canchola, Fan Zhang, and Zhoumeng Lin. 2025. “Machine Learning and Artificial Intelligence in Nanomedicine.” Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology 17 (4): e70027. https://doi.org/10.1002/wnan.70027.
Harvard
Chou, W. et al. (2025) ‘Machine Learning and Artificial Intelligence in Nanomedicine’, Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, 17(4), p. e70027. doi:10.1002/wnan.70027.
IEEE
W. Chou, A. Canchola, F. Zhang, and Z. Lin, “Machine Learning and Artificial Intelligence in Nanomedicine,” Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, vol. 17, no. 4, p. e70027, 2025, doi: 10.1002/wnan.70027.
BibTeX
@article{chou2025machine,
title = {{Machine Learning and Artificial Intelligence in Nanomedicine}},
author = {Chou, Wei‐Chun and Canchola, Alexa and Zhang, Fan and Lin, Zhoumeng},
journal = {Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology},
year = {2025},
volume = {17},
number = {4},
pages = {e70027},
doi = {10.1002/wnan.70027},
url = {https://doi.org/10.1002/wnan.70027}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- artificial intelligence
- machine learning
- nanomedicine
- nanoparticle design
- structure-function relationship
- protein corona
- DNA barcoding
- automated liquid handling
Work with this paper
Most-cited papers in Materials Science
- Electric Field Effect in Atomically Thin Carbon FilmsKostya S. Novoselov, Andre K. Geim, Sergey V. Morozov and 5 more · Science · 2004 · 67,474 citations
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesROBERT D. SHANNON · Acta Crystallographica Section A · 1976 · 66,944 citations
- Ab initio molecular dynamics for liquid metalsGeorg Kresse, J. Häfner · Physical review. B, Condensed matter · 1993 · 46,320 citations
- Helical microtubules of graphitic carbonSumio Iijima · Nature · 1991 · 43,639 citations
- The rise of grapheneAndre K. Geim, Kostya S. Novoselov · Nature Materials · 2007 · 40,328 citations
Questions about this paper
How do I cite this paper in APA style?
Chou, W., Canchola, A., Zhang, F., & Lin, Z. (2025). Machine Learning and Artificial Intelligence in Nanomedicine. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, 17(4), e70027. https://doi.org/10.1002/wnan.70027
How many times has this paper been cited?
205 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology: sign in and open the PDF from this page.
Who wrote this paper?
Wei‐Chun Chou, Alexa Canchola, Fan Zhang, Zhoumeng Lin.
What is the DOI of this paper?
10.1002/wnan.70027, permanently at https://doi.org/10.1002/wnan.70027. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.